IMMUNOTARGETS AND THERAPY : Impact Factor & More
eISSN: 2253-1556pISSN: 2253-1556
Open AccessShare this on:
Recommended pre-submission checks
Powered by 
Run standard language and technical checks to improve your manuscript – before you submit
Technical Compliance
Ensure manuscript complies with standard submission guidelines.
Language Quality
Improve clarity, grammar, and academic writing style.
A comprehensive report covering all these checks awaits you.
Topics Covered on IMMUNOTARGETS AND THERAPY
IMMUNOTARGETS AND THERAPY Journal Specifications
Indexed in the following public directories
Web of Science 
Scopus 
DOAJ 
SJR
| Overview | |
| Publisher | DOVE MEDICAL PRESS LTD |
| Language | English |
| Frequency | Continuous publication |
| Article Processing Charges | USD 2390 |
| Publication Time | 16 |
| Editorial Review Process | Anonymous peer review |
| General Details | |
| Language | English |
| Frequency | Continuous publication |
| Publication Start Year | 2012 |
| Publisher URL | Visit website |
| Website URL | Visit website |
| Publication Details | |
| Editorial Review Detail | |
| Information for authors | |
| Author instructions | Visit website |
| Copyright Details | Visit website |
| Deposit Policy | Sherpa/Romeo |
| License type | CC BY, CC BY-NC |
| OA statement | Visit website |
View less
Planning to publish in IMMUNOTARGETS AND THERAPY ?
Upload your Manuscript to get
- Degree of match
- Common matching concepts
- Additional journal recommendations
Recently Published Papers in IMMUNOTARGETS AND THERAPY
A Single-Cell-Derived CD8+ T-Cell State Plasticity Score for Prognostic Stratification and Characterization of Immune Responsiveness in Hepatocellular Carcinoma
- 21 Sep 2026
- ImmunoTargets and Therapy
Associations of Nonspecific Autoantibodies with Recurrent Pregnancy Loss and Pregnancy Outcomes Following Immunological Intervention: A Single-Centre Retrospective Cohort Study
- 19 Sep 2026
- ImmunoTargets and Therapy
ACBP/DBI Neutralization Stimulates Anticancer Immune Responses by Upregulating Lamin A in T Cells
- 18 Sep 2026
- ImmunoTargets and Therapy
A Myeloid-Specific Endogenous TRP1-CAR Knock-in Mouse Model for Melanoma-Targeted Immunotherapy
- 15 Sep 2026
- ImmunoTargets and Therapy
The Multifaceted Roles of STAT6: Implications for Precision Immunotherapeutics.
- 1 Sep 2026
- ImmunoTargets and therapy
VISTA Confers Renal Protection in Murine Hemorrhage/Infection-Induced Acute Kidney Injury: Associations with Altered NGAL and HMGB1 Expression.
- 1 Sep 2026
- ImmunoTargets and therapy
A Single-Cell-Derived CD8+ T-Cell State Plasticity Score for Prognostic Stratification and Characterization of Immune Responsiveness in Hepatocellular Carcinoma
- 21 Sep 2026
- ImmunoTargets and Therapy
Associations of Nonspecific Autoantibodies with Recurrent Pregnancy Loss and Pregnancy Outcomes Following Immunological Intervention: A Single-Centre Retrospective Cohort Study
- 19 Sep 2026
- ImmunoTargets and Therapy
ACBP/DBI Neutralization Stimulates Anticancer Immune Responses by Upregulating Lamin A in T Cells
- 18 Sep 2026
- ImmunoTargets and Therapy
A Myeloid-Specific Endogenous TRP1-CAR Knock-in Mouse Model for Melanoma-Targeted Immunotherapy
- 15 Sep 2026
- ImmunoTargets and Therapy
The Multifaceted Roles of STAT6: Implications for Precision Immunotherapeutics.
- 1 Sep 2026
- ImmunoTargets and therapy
VISTA Confers Renal Protection in Murine Hemorrhage/Infection-Induced Acute Kidney Injury: Associations with Altered NGAL and HMGB1 Expression.
- 1 Sep 2026
- ImmunoTargets and therapy
FAQs on IMMUNOTARGETS AND THERAPY
How long has IMMUNOTARGETS AND THERAPY been actively publishing? 
What is the publishing frequency of IMMUNOTARGETS AND THERAPY?
How many articles did IMMUNOTARGETS AND THERAPY publish last year?
What is the eISSN & pISSN for IMMUNOTARGETS AND THERAPY?
Who is the publisher of IMMUNOTARGETS AND THERAPY?
Check if your manuscript is a good match for
undefined
Upload your manuscript to get recommendations of journals
that have published papers similar to your manuscript
Drag and drop your file here
We accept manuscripts in English. File format: .doc and .docx | Maximum size: 10 MB | Word count: 200-300,000 words | File length: less than 100 pages
Do not have a manuscript right now? Use an abstract or summary
Your document is 100% secure & confidential We use 256-bit encryption for total security and
ISO/IEC 27001:2022 Certified
What all does the report include
01. Degree of Match
02. Common Topics
03. Additional
Recommendations
Recommendations